Table 2 Mean ± SD metabolic parameters at baseline and end of treatment
From: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
| Â | Baseline | p value | End of treatment | p value | ||
|---|---|---|---|---|---|---|
Losartan | Telmisartan | Â | Losartan | Telmisartan | ||
HOMA-IR | 5.78 ± 3.53 | 5.74 ± 3.35 | NS | 5.82 ± 2.66 | 4.24 ± 2.36 | < 0.05 |
FPG | 110.05 ± 14.56 | 109.08 ± 16.67 | NS | 113.20 ± 12.68 | 100.00 ± 11.99 | < 0.05 |
FPI | 20.47 ± 9.64 | 18.86 ± 10.89 | NS | 20.14 ± 9.49 | 16.93 ± 8.91 | < 0.06 |
2-hour OGTT | 137.42 ± 32.5 | 131.31 ± 42.05 | NS | 134.6 ± 26.71 | 113.85 ± 42.14 | < 0.01 |
HbA1c | 6.27 ± 0.29 | 6.45 ± 0.35 | NS | 6.28 ± 0.21 | 5.85 ± 0.18 | < 0.05 |